SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Cumberland Pharmaceuticals Plans Ifetroban DMD Drug Application Filing

Cumberland Pharmaceuticals said it plans to file a new drug application for its ifetroban DMD program.

CPIX

Related stories